AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

What's New in Molluscum Contagiosum? Advances in Understanding and Treating Molluscipoxvirus

Description

This presentation discusses recent advancements in understanding and treating molluscum contagiosum, a contagious skin infection caused by the molluscipoxvirus. The virus, characterized as a double-stranded DNA pox virus, primarily affects children and is often spread through wet conditions, such as swimming. The presentation highlights various symptoms, age demographics, and the significance of co-morbid conditions like atopic dermatitis, which can exacerbate the condition. The speaker emphasizes the contagious nature of the virus, particularly in communal settings and among family members. Diagnosis is complicated by the virus's ability to mimic other skin conditions. Discussion includes the immune response to molluscum, which can take upwards of two years to resolve in some cases, and the importance of clear communication with parents regarding expected duration and treatment options. Management includes a variety of therapies, though many are not well-tolerated by young children. The challenges of treatment and potential complications such as secondary infections and skin irritation are noted. Ultimately, the presenter underscores the need for effective treatments and strategies to address parents' concerns and the quality of life for affected children.

View more

Conclusions

  • Molluscum contagiosum is primarily a childhood infection caused by a poxvirus with bimodal peaks in incidence, particularly affecting toddlers and preschoolers.
  • The virus spreads via direct contact, especially when wet, with co-bathing being a common transmission route.
  • Molluscum can mimic other skin conditions like acne and dermatitis, complicating diagnosis.
  • The presence of associated dermatitis and atopic conditions increases the severity of symptoms and makes molluscum itchier.
  • Molluscum generally resolves on its own, with about 50% clearance at one year, and most cases resolving by two years; however, treatment may be necessary for persistent cases.
  • Atopic dermatitis can be triggered or exacerbated by molluscum, leading to prolonged itching and the need for more intensive management.
  • Parents often express significant concern over the appearance of molluscum in their children, leading to anxiety and a desire for treatment options.
  • Painless and well-tolerated treatment options are crucial, particularly given the high prevalence among young children.
  • The study highlights the importance of educating parents about the natural history of molluscum to manage their expectations regarding resolution time.
  • Silverberg NB. Cutis 2018; 102: 191-4.
  • Silverberg NB. J Am Acad Dermatol. 2000 Sep;43(3):503-7.
  • Han H. J Drugs Dermatol. 2023;22(2):182-189. doi:10.36849/JDD.7230
  • O'Connell C. Pediatr Dermatol. 2008; 25:553.
  • Luke JD. Pediatrics. 2010; 125: e423
  • Basdag H. Pediatr Dermatol. 2015; 32: 353.
  • Dohil M. JAAD. 2005; 54:47.
  • McCollum AM. Plos One. 2014;9: e103419.
  • Berger E. JAMA Dermatol. 2012; 148:1257.
  • Browning JC. Am J Clin Dermatol. 2023; 24:119.
  • Vakharia PP. Am J Clin Dermatol. 2018 Dec;19(6):791-803.
  • Sugarman JL. J Am Acad Dermatol. 2024 Feb;90(2):299-308.
  • Enns LL, Evans MS. Pediatr Dermatol. 2011 May-Jun;28(3):254-8.
  • Eichenfield LF, Siegfried E, Kwong P, McBride M, Rieger J, Glover D, Willson C, Davidson M,Burnett P, Olivadoti M. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum. Am J Clin Dermatol. 2021 Mar;22(2):257-265.